Pacific Biosciences of California, Inc.
- PACB
- NASDAQ
- Medical devices
- Long-Read Sequencing
- DNA Sequencing Technology
$1.73
Today −11.73%Quote Oct 16, 2026, 08:00 PM UTC
+25.36%over the last month
Max drawdown −39.7%From 1-month high −39.7%3 months +27.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$537.7M
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$1.35
−22.0% from here
Floor
$1.43
17.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PACBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $72.0M
- Product$33.0M45.8%
- Consumable$20.1M27.9%
- Instrument$12.8M17.8%
- Service And Other$6.1M8.4%
Industry
Medical devices
Employees
485
Founded
2000